ETFs
B
BIIB
Biogen Inc
215.50
-3.55-1.62%Closed19:58 09/18 EDT
OPEN/PREV CLOSE219.05/219.05
TODAY RANGE215.26-220.17
VOL2.64M
MARKET CAP31.84B
52 WEEK RANGE135.39-225.80
AVG VOL (3M)1.11M
% TURNOVER0.60%
TURNOVER--
P/E (TTM)38.16
% RANGE2.24%
EPS(TTM)5.65
P/E(FORWARD)35.15
P/B1.689
BVPS127.61
DIVIDEND--
P/S3.196
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP31.70B
SHARES OUTSTANDING147.75M
NEXT EARNINGS10/28-11/02
FREE FLOAT147.10M
LOT SIZE1
EX-DATE02/02/2017
News
Press Releases
Financial Reports
Profile
Seeking Alpha·3d ago
Looming biosimilar void risks $189B in lost U.S. healthcare savings: report
Seeking Alpha·3d ago
Biogen: Growth Is Back, But It Came At A Price
Seeking Alpha·3d ago
Roche succeeds in late-stage study for Lunsumio regimen in follicular lymphoma
Simply Wall St·5d ago
Biogen (BIIB) Wins China Approval For At Home Weekly Alzheimer’s Treatment
Seeking Alpha·6d ago
Goldman rebalances its short duration stock basket
NASDAQ·09/12 21:01
Biogen Sees Pivotal Pipeline Moment as It Expands Beyond Neurology